Boston, United States
PrescriberPoint, founded in 2021, is a dynamic player within the Health Care and Pharmaceutical industries, headquartered in the United States. The company operates a comprehensive platform designed to assist healthcare providers (HCPs) in streamlining the process of getting their patients onto therapy. By providing an extensive range of prescribing resources, workflow tools, and a blend of AI and human support, PrescriberPoint aims to minimize the effort required for patient treatment initiation.
Offering end-to-end support, the platform aids in treatment decisions, coverage investigation, prior authorizations, financial support, samples, patient education, and more, encompassing 35,000 branded, generic, and OTC drugs. The company highlights its ability to provide faster access to treatment, aligning with its slogan: "Helping providers get their patients on therapy."
Notably, PrescriberPoint secured a seed investment round on 01 February 2023, backed by reputed investors including Eli Lilly, Mastercard, Adobe Systems, and Pfizer. This investment indicates strong market potential and investor confidence in its innovative approach to improving healthcare workflows.
